Video & Transcript Research : 'pharmacy'

Page 9 of 98
HI

Hawaii 2026 Regular Session

CPC Public Hearing - Wed Mar 4, 2026 @ 2:00 PM HST

Consumer Protection & Commerce

Summary: The committee heard testimony on HB 1984 HD2, which would require government entities issuing building permits to create a self-certification process for certain behind-the-meter rooftop solar and energy storage systems, allowing approved applicants to proceed without waiting for standard permit review. The Public Utilities Commission and DLNR offered comments, and the Hawaii Solar Energy Association, Holoholo Energy, Photon Works Engineering, Malama Solar, RevoluSun, and others testified in strong support. Supporters said the bill would reduce permitting delays, lower costs, and help meet Hawaii’s renewable energy goals while still relying on licensed engineers, electricians, and county inspections for safety. Committee members asked about risk, existing county pilot programs, and whether self-certification had been used before; witnesses said the professional liability remains with licensed signers and that current automated review systems often flag minor issues that slow projects. The committee also noted 16 additional written testimonies in support. The committee then took up HB 1593 HD1, which would require HHFDC-financed affordable rental housing projects to allow residents to own or keep common household pets. The Hawaiian Humane Society testified that the bill is a top priority because housing restrictions are a major reason pets are surrendered and because many unhoused residents with pets avoid housing that does not allow animals. In response to questions, the Humane Society said concerns about pet-related damage are overstated, suggested pet behavior screening as a safeguard, and said it would be willing to work on broader private-market pet-friendly housing policies. Members raised concerns about whether allowing pets in public housing could create problems for residents who later transition to the private market, and the witness said California has a similar law and no major negative effects had been identified. Finally, the committee heard HB 2423 HD2, which would require that by January 1, 2028, diesel fuel sold in Hawaii for on-highway vehicles contain at least 5% biodiesel by volume. The Hawaii State Energy Office offered comments, and Hawaii Transportation Association and Pacific Biodiesel Technologies testified in support. Pacific Biodiesel argued the mandate would improve energy security, stabilize fuel prices amid global supply disruptions, and support local clean-fuel production. In response to questions, the company said its nameplate capacity is 5.5 million gallons per year and it has produced over 6 million gallons annually, but much of its output is tied up in standby generator contracts that can fluctuate. Witnesses said the mandate would provide a stable market signal and could support future investment in expanded local biodiesel production, including agricultural feedstock development and a possible second refinery. No votes or final actions were taken during the portion of the meeting provided.
NM

New Mexico 2026 Regular Session

Senate - Tax, Business and Transportation Feb 10th, 2026 at 04:43 pm

Senate Tax, Business & Transportation

Transcript Highlights:
  • But OSI said, you know, our PBMs, our pharmacy benefit managers in the IEBM...
  • Our pharmacy benefit managers in the IBAC should also do that.
  • Moving on, pharmacy benefit manager was written in several places to clarify.
  • The other problem is that the three-year period is included because, if you go to the pharmacy, you'll
  • And also, as you may find when you go to the pharmacy, it is a definite convenience for them.
Bills: SB20, SB21, SB166, SB177, SB181, SB189, SM6
AL

Alabama 2026 1st Special Session

Alabama House Health Committee Jan 28th, 2026

Health

Transcript Highlights:
  • Either physicians did not want to write it or pharmacies did not want to dispense it, and so patients
  • So, anyone who wants the vaccine can go to a pharmacy and if they fit the protocol and the safety checks
  • can go to a pharmacy and if they<00:18:45.200> fit<00:18:45.440> the<00:18:45.679>
  • We've worked with the Board of Pharmacy since that time to implement that process.
  • pharmacy that's willing to dispense it. pharmacy that's willing to dispense it. back<00:24:01.200
LA

Louisiana 2026 Regular Session

House of Representatives Mar 24th, 2026

Louisiana House Floor Meeting

LA

Louisiana 2026 Regular Session

House of Representatives Mar 23rd, 2026

Louisiana House Floor Meeting

LA

Louisiana 2026 Regular Session

Senate May 31st, 2026

Louisiana Senate Floor Meeting

Transcript Highlights:
  • It's an act to amend Title 22 relative to pharmacy benefit managers to provide for definitions and provide
  • for pharmacy reimbursements.
Summary: The Senate met with 29 members present, heard a prayer and national anthem presentation, and approved the journal without objection. The chamber then received multiple messages from the House on conference committee reports and concurrence actions, and took up a long calendar of Senate resolutions and House/Senate bills returned from the House with amendments. Several resolutions were adopted without objection, including commendations and requests for reports or studies, while others were left over or returned to the calendar. The Senate concurred in or adopted amendments on a series of bills covering registrar compensation (SB 25), broadband administration and reimbursement (SB 80), school safety master key boxes (SB 132), dental coverage for cancer treatment (SB 155), paid parental leave for educators (SB 157), election supervisor compensation days (SB 202), water utility service line replacement funding (SB 228), weight management services through the Office of Group Benefits (SB 250), medical debt protection (SB 414), Medicaid coverage of weight-loss medication (SB 443), and design-build authority for vertiport facilities (SB 513). It also adopted a House concurrent resolution urging backup motors for the St. Claude Avenue Bridge (HCR 32). One bill, SB 479 on removal of certain judges, had its amendments rejected and was sent to conference. The chamber then considered conference committee reports on several measures. Reports were adopted on SB 312 (labor organization dues and fees), SB 208 (veterans services and VA-related restrictions), SB 382 (workers’ compensation advisory council and reimbursement schedule timing), SB 389 (agent and athlete registration and fee review), and multiple House bills including HB 359 (party primary qualifying rules), HB 368 (New Orleans historic preservation lien procedures), HB 468 (wholesale residential real estate definitions), HB 552 (DWI-related responsive verdict language), HB 732 (motor vehicle fines/fees and hybrids), HB 870 and HB 1236 (pharmacy benefit manager and insurance provisions), and HB 1117 (prescription period issues). HB 210 on retroactivity was also adopted after debate. Several conference reports were temporarily passed over or returned to the calendar, including HB 953, and the Senate adjourned to reconvene the next morning for final work.
OK
Transcript Highlights:
  • House Bill 3538 is negotiated language between the pharmacy association and the pharmacy benefit manager
  • First, I want to say that I understand the independent pharmacies are struggling.
  • So your small town pharmacies that are filling 50 scripts a day, it's about $100 difference.
  • Do independent pharmacies make as much off a dispensing fee as PBM-owned pharmacies?
  • Fee as a PBM-owned pharmacy makes and dispensing fees. Thank you for the question.
LA

Louisiana 2026 Regular Session

House and Governmental Affairs May 12th, 2026

House and Governmental Affairs

Summary: The House and Governmental Affairs Committee met on May 12 with a quorum present and took up several measures. It first heard HCR 74, which would establish a Louisiana-United Kingdom Trade Commission modeled after the existing Louisiana-Ireland commission. The author said the commission would serve as an umbrella group to promote exchanges in trade, academics, financial services, economic development, and the arts, with no compensation for members. After brief questions and supportive testimony from a member familiar with the Ireland commission, the committee reported HCR 74 favorably. The committee then considered SCR 38, which repeals Joint Rule No. 7 related to the Atchafalaya Basin Program Oversight Committee. The author explained that the repeal was tied to a separate study commission on Atchafalaya Basin water quality, aimed at addressing sediment buildup, stagnant hypoxia, and harm to the fishing industry. Members discussed sediment management and water quality concerns, and the committee adopted a technical amendment to the title before reporting the resolution favorably, as amended. Finally, the committee began hearing Senate Bill 495 on campaign finance disclosures. The author described a series of changes, including raising the threshold for unitemized individual contributions to $200, adjusting when a PAC is considered to be participating in an election, extending the annual report deadline from February 28 to March 15, and allowing leadership PAC funds to cover replacement or repair of items damaged in connection with public office. The transcript cuts off during the bill presentation, so no final action on SB 495 is shown.
HI

Hawaii 2026 Regular Session

CPC Public Hearing - Tue Mar 24, 2026 @ 2:00 PM HST

Consumer Protection & Commerce

Transcript Highlights:
  • Moving on to SB 2047 SD2 HD1 relating to pharmacy benefit managers. a a property management company a
  • SB 2047 SD2 HD1, relating to pharmacy benefit managers, establishes certain requirements for pharmacy
  • benefit managers that reimburse contracting pharmacies for drugs on a maximum allowable cost basis.
  • Moving on to SB 247 SD2 HD1 relating to pharmacy benefit managers.
  • <01:13:29.320> benefit SD2 HD1 relating to pharmacy benefit SD2 HD1 relating to pharmacy benefit
Summary: The committee heard testimony on SB 2433 SD1 relating to condominiums, which would direct the condominium education trust fund toward educational resources for unit owners and require the Real Estate Commission to ensure owners’ interests are represented in funded activities and related rulemaking. Supporters, including the Hawaii Real Estate Commission and a condominium owner advocate, said owners need a seat at the table in condo governance and education efforts. Committee discussion focused on whether the bill was necessary, with the Real Estate Commission indicating it could already use the trust fund for owner education and that owners are already considered stakeholders, though not through a specific commission seat. No vote was taken during the excerpted discussion. The committee then took up SB 2047 SD2 HD1 on pharmacy benefit managers, which would set requirements for maximum allowable cost reimbursement, allow reverse-and-rebill claims after successful appeals, and authorize fines for violations. The Insurance Division offered comments, the Hawaii Pharmacists Association supported the measure with amendments and suggested future PBM reform funding, and Kaiser Permanente requested a technical amendment. A committee question raised whether the staffing and resource request for implementation was too large for a bill focused only on MAC pricing, and the witness said he would provide more data to the next committee. No final action was shown. Next was SB 2425 SD2 HD1 on health insurance and substance use disorder treatment, requiring insurers to honor written assignments of benefits to SUD providers and prohibiting anti-assignment clauses. Supporters described patients being unable to access treatment because of high out-of-pocket costs and said direct payment would reduce harm for people in recovery. HMSA opposed the bill but said it would begin direct payments to non-participating SUD facilities effective March 27, while continuing to object to the assignment-of-benefits portion because of fraud and balance-billing concerns; the Hawaii Association of Health Plans also opposed. Members questioned HMSA about reimbursement mechanics and why the bill was needed if coverage policies were already changing. Finally, the committee heard SB 3045 SD1 HD1, which would require coverage of continuous glucose monitors and related supplies, including for Medicaid managed care, under certain conditions. DHS and the Insurance Division offered comments, while SHPDA, Hilo Benioff Medical Center Foundation, and others supported the bill, citing inconsistent access and a case in which a woman allegedly died after being denied a CGM. HMSA said it already covers medically necessary CGMs and had updated its policy in 2025 for type 1 and insulin-dependent patients, but it raised concerns about expanding mandated coverage to type 2 and gestational diabetes and about supply impacts. The committee also discussed whether the bill duplicated existing coverage standards and why it had been introduced repeatedly. No votes or final dispositions were included in the excerpt.
OK

Oklahoma 2026 Regular Session

Health and Human Services REVISED Feb 9th, 2026 at 02:00 pm

Health and Human Services

Transcript Highlights:
  • to get advice on how to improve things in hospitals and stroke care and things having to do with pharmacies
  • They will sell it to the pharmacies at that price. The Most a pharmacy can charge is $55.
  • If a pharmacy continues to go higher than that, they will pull the product from that pharmacy.
TX
Transcript Highlights:
  • She does not have a pharmacy or a primary care facility.
  • House Bill 3233 prohibits pharmacy benefit managers (PBMs) from storing patient data of Texans in hostile
  • House Bill 3233 prohibits pharmacy benefit managers from storing patient data in a country that the U.S
TX

Texas 89th Regular

Public Health Apr 7th, 2025 at 03:30 pm

Public Health

Summary: The meeting of the public health committee focused on the pressing issue of opioid addiction in Texas, with a particular emphasis on House Bill 3717. Chairman Harris detailed the bill's intent to fund a grant program for Ibogaine clinical trials, framing it as a critical response to the ongoing opioid crisis. He shared poignant testimonies highlighting the struggles of families and veterans battling addiction and mental health issues. The conversation underscored the necessity of innovative treatments, like Ibogaine, which showed promising results in studies for reducing symptoms of withdrawal and PTSD.